Sort
48,018 grants matching “immunotherapy”
Elucidating the role of transcriptomics in driving ethnicity and ancestry-related disparities in colorectal cancer
$719,426Jane C. Figueiredo · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine
$719,412Obi L. Griffith · Washington University · U24 · FY2022 · CA
Development Fund
$719,048Michael Barry Kastan · Duke University · P30 · FY2025 · CA
Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma
$718,983Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
$718,958Brinda Emu · Yale University · R01 · FY2017 · CA
Development and maintenance of human glycan and phospholipid antibody repertoires
$718,871John Franklin Kearney · University Of Alabama At Birmingham · U19 · FY2023 · AI
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$718,818Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Effect of IL-21 treatment concurrent to ART and 3HP in Mtb/SIV co-infection
$718,758Riti Sharan · Texas Biomedical Research Institute · R56 · FY2024 · AI
Winship National Clinical Trials Network Lead Academic Participating Site
$718,680Kristin Higgins · Emory University · UG1 · FY2022 · CA
Winship National Clinical Trials Network Lead Academic Participating Site
$718,680Suresh S Ramalingam · Emory University · UG1 · FY2019 · CA
Winship National Clinical Trials Network Lead Academic Participating Site
$718,680Kristin Higgins · Emory University · UG1 · FY2023 · CA
Winship National Clinical Trials Network Lead Academic Participating Site
$718,680Suresh S Ramalingam · Emory University · UG1 · FY2020 · CA
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
$718,598Daniel B Stetson · University Of Washington · R01 · FY2022 · CA
Microneedles for treatment of peanut allergy
$718,524Harvinder Singh Gill · Texas Tech University · R01 · FY2018 · AI
Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs
$718,306James L Riley · University Of Pennsylvania · R01 · FY2024 · AI
Depleting exosomes to improve responses to immune therapy in HNSCC
$718,185Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · DE
Systems-level identification of key regulators deciding immune cell state
$718,083Wei Wang · University Of California, San Diego · R01 · FY2020 · AI
Immunotherapy of inflammation, autoimmune disease and cancer
$718,002Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity
$717,936Catherine Sibyl Diefenbach · New York University School Of Medicine · R01 · FY2022 · CA
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
$717,912Robert H Gilman · Johns Hopkins University · R01 · FY2023 · AI
Molecular Pharmacology of NKT Cell Agonists
$717,836Luc Teyton · Scripps Research Institute, The · R01 · FY2015 · AI
Molecular Pharmacology of NKT Cell Agonists
$717,836Luc Teyton · Scripps Research Institute, The · R01 · FY2014 · AI
Project 1: Physical modeling and dynamics of tumor cell migration mechanics
$717,814David J Odde · University Of Minnesota · U54 · FY2017 · CA
Mechanisms and Therapeutic Targeting of T cell Regulation in Heart Allograft Recipient Monkeys
$717,706Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AI
New Approaches To Passive Immunoprophylaxis
$717,699Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI